Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
636,030
-
Shares change
-
-573,875
-
Total reported value, excl. options
-
$757,000
-
Value change
-
-$869,302
-
Number of buys
-
7
-
Number of sells
-
-4
-
Price
-
$1.19
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2016
15 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q4 2016.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 636,030 shares
of 113,177,462 outstanding shares and own 0.56% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (270,222 shares), RENAISSANCE TECHNOLOGIES LLC (163,200 shares), GRT CAPITAL PARTNERS L.L.C. (94,978 shares), GEODE CAPITAL MANAGEMENT, LLC (31,264 shares), GOLDMAN SACHS GROUP INC (29,239 shares), NORTHERN TRUST CORP (16,962 shares), MORGAN STANLEY (15,639 shares), Acrospire Investment Management LLC (10,766 shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1,807 shares), and REILLY FINANCIAL ADVISORS, LLC (1,250 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.